SCHEMBL5961822

SCHEMBL5961822

C=CC(=O)OCOc1ccc(OCOc2ccc3c(c2)C(CC)c2cc(OC(=O)c4ccc(OCOC(=O)C=C)cc4)ccc2-3)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.34
MAPT P10636 5/20 0.34
CCNC P24863 1/20 0.34
CDK8 P49336 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
THRB P10828 2/20 0.33
GBA1 P04062 1/20 0.33
PDGFRB P09619 1/20 0.33
PDGFRA P16234 1/20 0.33
MEN1 O00255 1/20 0.33
PRSS1 P07477 1/20 0.33
ACR P10323 1/20 0.33
HIF1A Q16665 1/20 0.32
ALDH1A1 P00352 1/20 0.32
NPC1 O15118 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14088490 0.98 KMT2A (0.36) KMT2AMAPTCCNCCDK8THRB
SCHEMBL5961823 0.89 KMT2A (0.35) KMT2AMAPTCCNCCDK8TDP1
SCHEMBL11986163 0.87 KMT2A (0.36) KMT2AMAPTCCNCCDK8THRB
SCHEMBL16660342 0.85 GBA1 (0.40) KMT2AMAPTGBA1PDGFRBPDGFRA
SCHEMBL15480714 0.82 THRB (0.45) KMT2AMAPTTDP1L3MBTL1THRB
SCHEMBL13289441 0.82 KMT2A (0.37) KMT2AMAPTTDP1L3MBTL1THRB
SCHEMBL10308958 0.82 KMT2A (0.46) KMT2AMAPTCCNCCDK8TDP1
SCHEMBL13664616 0.81 HIF1A (0.35) KMT2AMAPTCCNCCDK8TDP1
SCHEMBL19759250 0.81 MAPT (0.35) KMT2AMAPTTDP1L3MBTL1THRB
SCHEMBL12242722 0.81 KMT2A (0.47) KMT2AMAPTCCNCCDK8TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8168734-B2 Lateral alpha-substituted acrylate compound and polymer thereof JNC CORPORATION (JP) 2012-05-01 US disclosed
US-20110144293-A1 LATERAL ALPHA-SUBSTITUTED ACRYLATE COMPOUND AND POLYMER THEREOF CHISSO CORPORATION (JP) 2011-06-16 US disclosed
US-7919648-B2 Lateral α-substituted acrylate compound and polymer thereof CHISSO CORPORATION (JP) 2011-04-05 US disclosed
US-20070134447-A1 Lateral a-substituted acrylate compound and polymer thereof CHISSO CORPORATION 2007-06-14 US disclosed
US-7157124-B2 Polymerizable compounds and their polymers CHISSO PETROCHEMICAL CORPORATION (JP) 2007-01-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144293-A1 LATERAL ALPHA-SUBSTITUTED ACRYLATE COMPOUND AND POLYMER THEREOF LEF1, AFF1, CNKSR1 KMT2A 1856/4885MAPT 3921/4885CCNC 1266/4885
US-20070134447-A1 Lateral a-substituted acrylate compound and polymer thereof AFF1, CNKSR1, LEF1 KMT2A 922/4885MAPT 3961/4885CCNC 1236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.